Patents by Inventor Joseph Peter Sauer

Joseph Peter Sauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3-yl)acetonitrile monohydrochloride
    Publication number: 20030157169
    Abstract: A controlled release formulation of an acetonitrile compound and its use in the treatment and/or prophylaxis of certain disorders.
    Type: Application
    Filed: August 28, 2002
    Publication date: August 21, 2003
    Applicant: SmithKline Beecham Corporation and SmithKline Beecham p.l.c.
    Inventors: Joseph Peter Sauer, Susan Marie Milosovich, William Thomas Muldoon, James Albert Napper, Laurence Rousseau
  • Controlled release dosage form of [R-(Z)]-&agr;-(methoxyimino)-&agr;-(1-azabicyclo[2.2.2]oct-3yl) acetonitrile monohydrochloride
    Patent number: 6468560
    Abstract: A controlled release formulation of an acetonitrile compound and its use in the treatment and/or prophylaxis of certain disorders.
    Type: Grant
    Filed: September 19, 2001
    Date of Patent: October 22, 2002
    Assignees: SmithKline Beecham p.l.c., SmithKline Beecham Corporation
    Inventors: Joseph Peter Sauer, Susan Marie Milosovich, William Thomas Muldoon, James Albert Napper, Laurence Rousseau
  • Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3yl) acetonitrile monohydrochloride
    Publication number: 20020031550
    Abstract: A controlled release formulation of an acetonitrile compound and its use in the treatment and/or prophylaxis of certain disorders.
    Type: Application
    Filed: September 19, 2001
    Publication date: March 14, 2002
    Applicant: SmithKline Beecham Corporation and SmithKline Beecham p.l.c.
    Inventors: Joseph Peter Sauer, Susan Marie Milosovich, William Thomas Muldoon, James Albert Napper, Laurence Rousseau
  • Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2.]oct-3-yl)acetonitrile monohydrochloride
    Publication number: 20010003588
    Abstract: A controlled release formulation of an acetonitrile compound and its use in the treatment and/or prophylaxis of certain disorders.
    Type: Application
    Filed: January 12, 2001
    Publication date: June 14, 2001
    Applicant: SmithKline Beecham Corporation
    Inventors: Joseph Peter Sauer, Susan Marie Milosovich, William Thomas Muldoon, James Albert Napper, Laurence Rousseau
  • Stabilized tablet formulation
    Patent number: 5882681
    Abstract: Invented are stabilized tablet formulations of substituted 3,5-diene steroidal compounds. Also invented are methods of preparing stabilized tablet formulations of substituted 3,5-diene steroidal compounds.
    Type: Grant
    Filed: May 11, 1995
    Date of Patent: March 16, 1999
    Assignee: SmithKline Beecham Corporation
    Inventors: Patrick Gerard Faulkner, Mark Warren Fisher, Joseph Peter Sauer, Carlos Roberto Hernandez
  • Stabilized tablet formulation
    Patent number: 5665390
    Abstract: Invented are stabilized tablet formulations of substituted 3,5-diene steroidal compounds. Also invented are methods of preparing stabilized tablet formulations of substituted 3,5-diene steroidal compounds.
    Type: Grant
    Filed: May 26, 1995
    Date of Patent: September 9, 1997
    Assignee: SmithKline Beecham Corporation
    Inventors: Patrick Gerard Faulkner, Mark Warren Fisher, Joseph Peter Sauer, Carlos Roberto Hernandez